The First Phase Key details and approval criteria for liraglutide (Saxenda) for weight management include a target patient age of 18 years and older with a body mass index (BMI) of 30 kg/m2 or greater, or a BMI of 27 kg/m2 or greater with at least one weight-related condition such as hypertension, type 2 diabetes, or dyslipidemia
GLP-1 agonists are a class of medications initially developed to treat type 2 diabetes that have since proven highly effective for weight loss
The cycle pricing covers a full intake with a licensed provider, lab evaluation when clinically indicated, the compounded medication from a 503A pharmacy, individualized dosing, injection training in person, and follow-up
The gut microbiome needs time to re-establish equilibrium without the medication influence
Free-radical neutralizing antioxidants and mitochondrial enhancing micronutrients
Because thyroid hormones are considered homeostasis-maintaining hormones, symptoms of an underactive thyroid can be widespread and affect many different aspects of your life, including your weight, mood, and mental performance
